Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, and biological crop protection products. It also offers products and solutions for the prevention and treatment of diseases in companion and farm animals. The company markets its products under Adalat, Redoxon, Baytril, Xofigo, Nativo, Serenade, Canesten, Afrin, Cydectin and Seresto brand names. Bayer distributes its products directly to farmers and through pharmacies, retailers, wholesalers, hospitals, veterinarians, supermarkets and drugstore chains. It has business presence in the Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. The company is headquartered in Leverkusen, Germany.Scope
- Detailed information on Bayer AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
- An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
- Intelligence on Bayer AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Bayer AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bayer AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Bayer AG's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Bayer AG: Company Overview
- Bayer AG: Overview and Key Facts
- Bayer AG: Overview
- Bayer AG: Key Facts
- Bayer AG: Key Employees
- Bayer AG: Key Employee Biographies
- Bayer AG: Major Products and Services
- Bayer AG: Management Statement
- Bayer AG: Locations and Subsidiaries
- Bayer AG: Key Competitors
- Bayer AG: Company Analysis
- Bayer AG: Business Description
- Bayer AG: SWOT Analysis
- Bayer AG: SWOT Overview
- Bayer AG: Strengths
- Bayer AG: Weaknesses
- Bayer AG: Opportunities
- Bayer AG: Threats
- Bayer AG: Corporate Financial Deals Activity
- Bayer AG: Financial Deals Overview
- Bayer AG: Targets and Partners
- Bayer AG: Top Deals 2019 - 2023YTD*
- Bayer AG: Advisors
- Bayer AG: Top Legal Advisors
- Bayer AG: Top Financial Advisors
- Bayer AG: Mergers and Acquisitions
- Bayer AG: Corporate Venturing
- Bayer AG: Capital Raising
- Bayer AG: Partnership
- Bayer AG: Divestments
- Bayer AG: Private Equity and Ownership
- Bayer AG: Recent Developments
- Bayer AG: News and Events Summary
- Bayer AG: Contracts
- Bayer AG: Market Developments
- Bayer AG: Regulatory and Legal Events
- Bayer AG: Research & Development
- Bayer AG: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About the Publisher
- Table 1: Bayer AG: Key Facts
- Table 2: Bayer AG: Key Employees
- Table 3: Bayer AG: Locations and Subsidiaries
- Table 4: Bayer AG: Key Competitors
- Table 5: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Bayer AG: M&A Activity by Geography (TTM*)
- Table 7: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Table 8: Bayer AG: M&A Average Deal Size - Value (US$m)
- Table 9: Bayer AG: Targets and Partners
- Table 10: Bayer AG: Top Deals 2019 - 2023YTD*
- Table 11: Bayer AG: Legal Advisor Ranking by Value (US$m)
- Table 12: Bayer AG: Financial Advisor Ranking by Value (US$m)
- Table 13: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
- Table 14: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
- Table 15: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Table 16: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
- Table 17: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
- Table 18: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
- Table 19: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
- Table 20: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
- Table 21: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
- Table 22: Bayer AG: Divestments by Geography (2019 - YTD*2023)
- Table 23: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Table 24: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
- Table 25: Bayer AG: News and Events Summary
- Table 26: Bayer AG: Contracts
- Table 27: Bayer AG: Market Developments
- Table 28: Bayer AG: Regulatory and Legal Events
- Table 29: Bayer AG: Research & Development
- Table 30: Bayer AG: Strategy and Operations
- Figure 1: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Bayer AG: M&A Activity by Geography (TTM*)
- Figure 3: Bayer AG: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
- Figure 4: Bayer AG: M&A Average Deal Size - Value (US$m)
- Figure 5: Bayer AG: M&A Volume and Value Trend (2019 - YTD*2023)
- Figure 6: Bayer AG: M&A Activity by Geography (2019 - YTD*2023)
- Figure 7: Bayer AG: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
- Figure 8: Bayer AG: Corporate Venturing by Geography (2019 - YTD*2023)
- Figure 9: Bayer AG: Capital Raising Volume and Value Trend (2019 - YTD*2023)
- Figure 10: Bayer AG: Capital Raising by Deal Type (2019 - YTD*2023)
- Figure 11: Bayer AG: Partnership Volume and Value Trend (2019 - YTD*2023)
- Figure 12: Bayer AG: Partnership Trend by Deal Type (2019 - YTD*2023)
- Figure 13: Bayer AG: Divestments Volume and Value Trend (2019 - YTD*2023)
- Figure 14: Bayer AG: Divestments by Geography (2019 - YTD*2023)
- Figure 15: Bayer AG: Private Equity and Ownership Volume and Value Trend (2019 - YTD*2023)
- Figure 16: Bayer AG: Private Equity and Ownership Volume by Deal Type (2019 - YTD*2023)
